
|Articles|August 1, 2002
The American Journal of Managed Care
- August 2002
- Volume 8
- Issue 8
The Comparative Clinical and Economic Benefits of Drugs Should be Established and Discussed as Part of any Formulary Decision Process
Advertisement
Articles in this issue
over 23 years ago
A New Era of Leadershipover 23 years ago
The Potential of Pill Splitting to Achieve Cost Savingsover 23 years ago
Rational Use of Antibiotics to Treat Respiratory Tract Infectionsover 23 years ago
Reducing Cesarean Delivery Rates in Managed Care OrganizationsNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
2
Long-Term Trial Shows Durable Efficacy, QOL Gains With Nirogacestat in Desmoid Tumors
3
Top 5 Most-Read Multiple Sclerosis Articles of 2025
4
Number of Medicare Beneficiaries With HIV Expected to Double in Next Decade
5






































